149 related articles for article (PubMed ID: 15895362)
1. Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells.
Ohguchi K; Banno Y; Nakagawa Y; Akao Y; Nozawa Y
J Cell Physiol; 2005 Dec; 205(3):444-51. PubMed ID: 15895362
[TBL] [Abstract][Full Text] [Related]
2. Involvement of phospholipase D1 in collagen type I production of human dermal fibroblasts.
Ohguchi K; Banno Y; Akao Y; Nozawa Y
Biochem Biophys Res Commun; 2006 Oct; 348(4):1398-402. PubMed ID: 16919239
[TBL] [Abstract][Full Text] [Related]
3. Involvement of phospholipase D1 in melanogenesis of mouse B16 melanoma cells.
Ohguchi K; Banno Y; Akao Y; Nozawa Y
J Biol Chem; 2004 Jan; 279(5):3408-12. PubMed ID: 14615486
[TBL] [Abstract][Full Text] [Related]
4. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
5. Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR.
Rosner M; Hengstschläger M
Oncogene; 2011 Nov; 30(44):4509-22. PubMed ID: 21602892
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of melanogenesis by phospholipase D2 through ubiquitin proteasome-mediated degradation of tyrosinase.
Kageyama A; Oka M; Okada T; Nakamura S; Ueyama T; Saito N; Hearing VJ; Ichihashi M; Nishigori C
J Biol Chem; 2004 Jun; 279(26):27774-80. PubMed ID: 15067002
[TBL] [Abstract][Full Text] [Related]
7. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase.
Tang X; Wang L; Proud CG; Downes CP
Biochem J; 2003 Aug; 374(Pt 1):137-43. PubMed ID: 12747804
[TBL] [Abstract][Full Text] [Related]
9. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells.
Jang JY; Kim HN; Kim YR; Choi WY; Choi YH; Shin HK; Choi BT
J Ethnopharmacol; 2011 Oct; 137(3):1207-14. PubMed ID: 21816215
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-2 regulates melanin synthesis via protein kinase C βII-mediated tyrosinase activation.
Jung H; Chung H; Chang SE; Choi S; Han IO; Kang DH; Oh ES
Pigment Cell Melanoma Res; 2014 May; 27(3):387-97. PubMed ID: 24472179
[TBL] [Abstract][Full Text] [Related]
11. Activation of neurokinin-1 receptor by substance P inhibits melanogenesis in B16-F10 melanoma cells.
Ping F; Shang J; Zhou J; Song J; Zhang L
Int J Biochem Cell Biol; 2012 Dec; 44(12):2342-8. PubMed ID: 23041339
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
[TBL] [Abstract][Full Text] [Related]
13. p70 S6K1 nuclear localization depends on its mTOR-mediated phosphorylation at T389, but not on its kinase activity towards S6.
Rosner M; Schipany K; Hengstschläger M
Amino Acids; 2012 Jun; 42(6):2251-6. PubMed ID: 21710263
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
15. A derivative of 2-aminothiazole inhibits melanogenesis in B16 mouse melanoma cells via glycogen synthase kinase 3β phosphorylation.
Kim SY; Hahn HG; Nam KD; Park KC; Yun HY; Baek KJ; Kwon NS; Kim DS
J Pharm Pharmacol; 2011 Aug; 63(8):1031-6. PubMed ID: 21718286
[TBL] [Abstract][Full Text] [Related]
16. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
[TBL] [Abstract][Full Text] [Related]
17. Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathway.
Markova B; Albers C; Breitenbuecher F; Melo JV; Brümmendorf TH; Heidel F; Lipka D; Duyster J; Huber C; Fischer T
Oncogene; 2010 Feb; 29(5):739-51. PubMed ID: 19881535
[TBL] [Abstract][Full Text] [Related]
18. Effect of Angelica gigas extract on melanogenesis in B16 melanoma cells.
Lv N; Koo JH; Yoon HY; Yu J; Kim KA; Choi IW; Kwon KB; Kwon KS; Kim HU; Park JW; Park BH
Int J Mol Med; 2007 Nov; 20(5):763-7. PubMed ID: 17912471
[TBL] [Abstract][Full Text] [Related]
19. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR.
Hou G; Xue L; Lu Z; Fan T; Tian F; Xue Y
Cancer Lett; 2007 Aug; 253(2):236-48. PubMed ID: 17360108
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]